GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
5,357
Funds Holding Change
+353
Funds Holding Growth
+7%
Value
$1.22T
Holding in Top 10
668
Top 10 Change
-195
Top 10 Growth
-23%
Value Growth
-12%
New
647
Increased
1,956
Reduced
2,475
Closed
201
Capital Inflow
$54.2B
Capital Outflow
$47.2B
Net Capital Flow
+$7.08B
Capital Flow Change
+$10.7B
Calls
$22.1B
Puts
$23B
Net Calls
-$966M
Put/Call Ratio
1.04